5,6-DICHLORO-N-(1-METHYLETHYL)-1-(2,3,5-TRI-O-ACETYL-.BETA.-L-RIBOFURANOSYL)-1H-BENZIMIDAZOL-2-AMINE
UNII 56A2XL5T69
Substance Identification & Data
This profile provides standardized clinical and technical data for 5,6-dichloro-n-(1-methylethyl)-1-(2,3,5-tri-o-acetyl-.beta.-l-ribofuranosyl)-1h-benzimidazol-2-amine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 56A2XL5T69.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 176161-56-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H25Cl2N3O7 DVCZAQGYYRGCCQ-MUGJNUQGSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5,6-dichloro-n-(1-methylethyl)-1-(2,3,5-tri-o-acetyl-.beta.-l-ribofuranosyl)-1h-benzimidazol-2-amine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.